Screener
AnaptysBio, Inc. ANAB Income Tax
Income Tax at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by AnaptysBio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The source filing: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219515
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Other (expense) income, net | (1) | 1,902 |
| Total other expense, net | (18,207) | (11,746) |
| Loss before income taxes | (52,844) | (39,285) |
| Provision for income taxes | (40) | (44) |
| Net loss | (52,884) | (39,329) |
| Other comprehensive loss: | ||
| Unrealized loss on available-for-sale securities | (122) | (144) |
| Comprehensive loss | $(53,006) | $(39,473) |
Item 1. Consolidated Financial Statements
FAQ
- What is AnaptysBio, Inc.'s income tax?
- AnaptysBio, Inc. (ANAB) reported income tax of $40K in Q1 2026.
- How has AnaptysBio, Inc.'s income tax changed year-over-year?
- AnaptysBio, Inc.'s income tax decreased by 9.1% year-over-year, from $44K to $40K.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.
Ask your AI about AnaptysBio, Inc.'s income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude